Overall rates of chronic illnesses such as diabetes, multiple schlerosis (MS) and rheumatoid arthritis (RA) are expected to skyrocket in the coming years. Treating these diseases successfully—and managing their associated health care costs—will depend in large part on patient adherence to medication regimens that may require daily, biweekly or monthly injections.
More patients requiring such treatment increases the demand for syringes and the need to train people how to self-inject medications in their homes. To address that issue, Noble, a provider of tailored training for prefilled syringes, autoinjectors, wearable injection devices, inhalers and medication adherence, recently introduced a product demonstration platform devoted to safety and patient compliance.